國立高雄大學圖資館 |

Language: English

Back

The natural anti-gal antibody as foe...

Galili, Uri,

The natural anti-gal antibody as foe turned friend in medicine /

Record Type:	Electronic resources : Monograph/item
Title/Author:	The natural anti-gal antibody as foe turned friend in medicine /Uri Galili, PhD.
Author:	Galili, Uri,
Description:	1 online resource (xviii, 300 pages) :illustrations.
Subject:	Antigens.
Online resource:	https://www.sciencedirect.com/science/book/9780128133620
ISBN:	9780128133637$q(electronic bk.)

The natural anti-gal antibody as foe turned friend in medicine /
Galili, Uri,

The natural anti-gal antibody as foe turned friend in medicine /Uri Galili, PhD. - 1 online resource (xviii, 300 pages) :illustrations.

Includes bibliographical references and index.

Anti-gal in humans and its antigen the ?-gal epitope -- Why do we produce anti-gal -- Anti-gal comprises most of anti-blood group b antibodies -- Anti-gal interaction with Trypansoma, Leishmania, and Plasmodium parasites -- Anti-gal b cells are tolerized by a ?-gal epitopes in the absence of t cell help -- Anti-gal and other immune barriers in xenotransplantation -- Anti-gal IgE mediates allergies to red meat -- Anti-gal and autoimmunity -- Anti-gal-mediated amplification of viral vaccine efficacy -- Cancer immunotherapy by anti-gal-mediated in situ conversion of tumors into autologous vaccines -- Anti-gal as cancer cell destroying antibody and as antibiotics targeted by ?-gal bifunctional molecules -- Acceleration of wound and burn healing by anti-gal/?-gal nanoparticles interaction -- Anti-gal and anti-non gal antibodies in regeneration of extracellular matrix bio-implants -- Post infarction regeneration of ischemic myocardium by intramyocardial injection of ?-gal nanoparticles -- Regeneration of injured spinal cord and peripheral nerves by ?-gal nanoparticles -- Inhalation of ?-gal/sialic acid liposomes for decreasing influenza virus infection.

The Natural Anti-Gal Antibody as Foe Turned Friend in Medicine provides a comprehensive review of the natural anti-Gal antibody, which is the most abundant antibody in humans constituting 1̃% of immunoglobulins and the carbohydrate antigen it recognizes, the?-gal epitope. It discusses the discovery of this antigen/antibody system, its evolution in mammals, the pathological effects of this antibody, and its possible use in various therapies in humans. Most significantly, the book discusses microbial and regenerative therapies in which an antibody present in all humans may be harnessed as an in vivo pharmaceutical agent that enables a wide variety of therapies. Some of these therapies are described as experimental studies that are compiled in this book, other already studied therapies in the area of cancer immunotherapy are also included in this book.

Specialized.

ISBN: 9780128133637$q(electronic bk.)Subjects--Topical Terms:

246106
Antigens.
Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: QR187.A1

Dewey Class. No.: 616.0792

National Library of Medicine Call No.: QW 573

The natural anti-gal antibody as foe turned friend in medicine /
LDR:03306cmm a2200337 i 4500 001 561738
006 m o d
007 cr |n|||||||||
008 200213t20182018enka fob 001 0 eng d
020 $a 9780128133637$q(electronic bk.)
020 $a 0128133635$q(electronic bk.)
020 $a 9780128133620
020 $a 0128133627
035 $a (OCoLC)1004483432 $z (OCoLC)1003284633 $z (OCoLC)1003314355
035 $a els69900475
040 $a CNCGM $b eng $e rda $e pn $c CNCGM $d N $d IDEBK $d EBLCP $d N $d OPELS $d OCLCF $d MERER $d OCLCQ $d YDX $d NLE $d UPM $d OCLCQ $d TXM $d OCLCQ $d OCLCO $d OCLCA $d OCLCQ $d CASUM $d OCLCO $d D6H $d DKU $d OCLCO $d SNK $d OCLCQ
041 0 $a eng
050 4 $a QR187.A1
060 4 $a QW 573
082 0 4 $a 616.0792 $2 23
100 1 $a Galili, Uri, $e author. $3 846258
245 1 4 $a The natural anti-gal antibody as foe turned friend in medicine / $c Uri Galili, PhD.
264 1 $a London, United Kingdom : $b Academic Press, an imprint of Elsevier, $c [2018]
264 4 $c ©2018
300 $a 1 online resource (xviii, 300 pages) : $b illustrations.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
504 $a Includes bibliographical references and index.
505 0 $a Anti-gal in humans and its antigen the ?-gal epitope -- Why do we produce anti-gal -- Anti-gal comprises most of anti-blood group b antibodies -- Anti-gal interaction with Trypansoma, Leishmania, and Plasmodium parasites -- Anti-gal b cells are tolerized by a ?-gal epitopes in the absence of t cell help -- Anti-gal and other immune barriers in xenotransplantation -- Anti-gal IgE mediates allergies to red meat -- Anti-gal and autoimmunity -- Anti-gal-mediated amplification of viral vaccine efficacy -- Cancer immunotherapy by anti-gal-mediated in situ conversion of tumors into autologous vaccines -- Anti-gal as cancer cell destroying antibody and as antibiotics targeted by ?-gal bifunctional molecules -- Acceleration of wound and burn healing by anti-gal/?-gal nanoparticles interaction -- Anti-gal and anti-non gal antibodies in regeneration of extracellular matrix bio-implants -- Post infarction regeneration of ischemic myocardium by intramyocardial injection of ?-gal nanoparticles -- Regeneration of injured spinal cord and peripheral nerves by ?-gal nanoparticles -- Inhalation of ?-gal/sialic acid liposomes for decreasing influenza virus infection.
520 $a The Natural Anti-Gal Antibody as Foe Turned Friend in Medicine provides a comprehensive review of the natural anti-Gal antibody, which is the most abundant antibody in humans constituting 1̃% of immunoglobulins and the carbohydrate antigen it recognizes, the?-gal epitope. It discusses the discovery of this antigen/antibody system, its evolution in mammals, the pathological effects of this antibody, and its possible use in various therapies in humans. Most significantly, the book discusses microbial and regenerative therapies in which an antibody present in all humans may be harnessed as an in vivo pharmaceutical agent that enables a wide variety of therapies. Some of these therapies are described as experimental studies that are compiled in this book, other already studied therapies in the area of cancer immunotherapy are also included in this book.
521 $a Specialized.
650 0 $a Antigens. $3 246106
650 0 $a Antigen-antibody reactions. $3 845929
650 1 2 $a Antigen-Antibody Reactions. $3 846259
655 4 $a Electronic books. $2 local. $3 214472
856 4 0 $u https://www.sciencedirect.com/science/book/9780128133620